Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ossifix Orthopedics is a U.S. orthopedic medical device and biologics company focused on fixation products made from human allograft bone rather than permanent metal implants. The company develops and manufactures single-use pin, screw, and plate systems and related instrumentation for orthopedic procedures, with early commercial emphasis on the Javelin allograft bone pin. It has also introduced a demineralized bone matrix product marketed as Crunch/DBM for bone regeneration applications. Ossifix appears to operate as a subsidiary of Umbra Applied Technologies Group following a 2020 acquisition, with manufacturing centered in Austin, Texas. Its products are aimed at small bone, extremity, sports medicine, and adjacent reconstructive markets where biointegrative or resorbable fixation may offer advantages over traditional hardware.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ossifix Orthopedics.